Mylan launches generic Axert

PITTSBURGH — Mylan on Tuesday announced that it had launched it generic version of Axert (almotriptan) tablets. The drug is indicated for acute migraine treatment in adults and acute migraines lasting more than four hours when untreated in adolescents aged 12 to 17.

The tablets will be available in 6.25- and 12.5-mg dosage strengths. The drug had U.S. sales of $29.2 million for the 12 months ended June 30.